World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 20 June 2016
Main ID:  NCT02780895
Date of registration: 12/05/2016
Prospective Registration: No
Primary sponsor: Celavie Bioscences, LLC
Public title: Parkinsonian Brain Repair Using Human Stem Cells HSCfPD
Scientific title: Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease
Date of first enrolment: May 2014
Target sample size: 8
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT02780895
Study type:  Interventional
Study design:  Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 1
Countries of recruitment
Mexico
Contacts
Name:     Oleg Kopyov, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Celavie Bioscences, LLC
Name:     Ignacio Madrazo, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Hospital Angeles del Pedregal
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of idiopathic PD with tremor, rigidity or hypokinesia as major symptoms.

- A two to twenty-five-year history of PD with significant medical management or
difficulty in medical management.

- A definite response to levodopa compounds with inadequately relieved of symptoms, or
severe secondary effects of the drug.

- Good general health.

- A strong will or desire to have the procedure after being fully informed of its
experimental nature.

Exclusion Criteria:

- History of repeated strokes with stepwise progression of parkinsonian features

- History of repeated head injury

- History of definite encephalitis

- Oculogyric crises (unless drug-induced)

- Neuroleptic treatment at onset of symptoms

- Supranuclear gaze palsy

- Cerebellar signs

- Babinski sign

- Presence of cerebral tumor or communicating hydrocephalus on CT scan

- Sustained remission or negative response to an adequate dose of levodopa

- Patients with parkinsonism other than Idiopathic PD



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Idiopathic Parkinson Disease
Intervention(s)
Drug: Human Stem Cells
Primary Outcome(s)
Safety as Measured by the Number and Severity of Adverse Events [Time Frame: three years]
Secondary Outcome(s)
Beck Anxiety Inventory (BAI) [Time Frame: three years]
Minnesota Multiphasic Personality Inventory (MMPI) [Time Frame: three years]
Sensory-Perceptual Examination [Time Frame: three years]
Trailmaking Test (TMT) [Time Frame: three years]
Benton Facial Recognition Test [Time Frame: three years]
Benton Judgment of Line Orientation (JLO) [Time Frame: three years]
Brief Test of Attention (BTA) [Time Frame: three years]
Coping Responses Inventory (CRI) [Time Frame: three years]
DTBZ ([18F]9-fluoropropyl-(+)-dihydrotetrabenazine) uptake [Time Frame: three years]
Hand Dynamometer [Time Frame: three years]
Controlled Oral Word Association Test (COWAT) [Time Frame: three years]
Delis-Kaplan Executive Function Scale (DKEFS) [Time Frame: three years]
California Verbal Learning Test (CVLT) [Time Frame: three years]
Cognitive Estimation Test (CET) [Time Frame: three years]
Finger Tapping [Time Frame: three years]
Halstead Category Test [Time Frame: three years]
FDOPA (L-3,4-dihydroxy-6-(18)F-fluorophenylalanine) uptake [Time Frame: three years]
Intelligence Kaufman Brief Intelligence Test (KBIT) [Time Frame: three years]
Hooper Visual Organization Test (VOT) [Time Frame: three years]
Stroop Test [Time Frame: three years]
Raclopride uptake [Time Frame: three years]
Rey Complex Figure Test (RCFT) [Time Frame: three years]
Complex Ideational Material [Time Frame: three years]
Efficacy as measured by the Unified Parkinson Disease Rating Scale (UPDRS) [Time Frame: three years]
Life Stressors and Social Resources Inventory (LISRES) [Time Frame: three years]
Mattis Dementia Rating Scale (DRS) [Time Frame: three years]
Auditory Consonant Trigrams (ACT) [Time Frame: three years]
Beck Depression Inventory (BDI) [Time Frame: three years]
Barona Demographic Equation [Time Frame: three years]
Benton Visual Retention Test (BVRT-R) [Time Frame: three years]
Grooved Pegboard [Time Frame: three years]
Hamilton Depression Scale (HDS) [Time Frame: three years]
Continuous Performance Tests (CPT) [Time Frame: three years]
Paced Auditory Serial Addition Test (PASAT) [Time Frame: three years]
State-Trait Anxiety Inventory (STAI) [Time Frame: three years]
Wechsler Adult Intelligence Scale (WAIS) [Time Frame: three years]
North American Adult Reading Test (NAART) [Time Frame: three years]
Parkinson's Disease Questionnaire (PDQ) [Time Frame: three years]
Raven's Progressive Matrices [Time Frame: three years]
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [Time Frame: three years]
Ways of Coping Questionnaire [Time Frame: three years]
Wechsler Abbreviated Scale of Intelligence (WASI) [Time Frame: three years]
Rey Auditory Verbal Learning Test (RAVLT) [Time Frame: three years]
Token Test [Time Frame: three years]
Wide Range AchievementTest (WRAT) [Time Frame: three years]
Wisconsin Card Sorting Test (WCST) [Time Frame: three years]
Wechsler Memory Scale (WMS) [Time Frame: three years]
Boston Naming Test (BNT) [Time Frame: three years]
Digit and Visual Spans [Time Frame: three years]
Pro?le of Mood States (POMS) [Time Frame: three years]
Sentence Repetition [Time Frame: three years]
Wechsler Test of Adult Reading (WTAR) [Time Frame: three years]
Secondary ID(s)
CMN2012-027
OK99-2014-2017
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hospital Angeles del Pedregal
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history